One pill to fight malaria? new drug trial seeks faster cure
NCT ID NCT07235020
Summary
This study tested a new oral drug called INE963 for treating uncomplicated malaria. It involved 52 adults with the infection who received a single dose at different levels. The main goal was to see how quickly the drug cleared the malaria parasites from the blood and to check if it was safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Novartis Investigative Site
Banfora, Burkina Faso
-
Novartis Investigative Site
Azaguié, BP 173, Côte d’Ivoire
-
Novartis Investigative Site
Lambaréné, BP 242, Gabon
-
Novartis Investigative Site
Navrongo, VWJ6+8WF, Ghana
-
Novartis Investigative Site
Kisumu, 40100, Kenya
-
Novartis Investigative Site
Kampala, Uganda
Conditions
Explore the condition pages connected to this study.